Pentadeca Arginate vs GHK-Cu
Side-by-side comparison of Pentadeca Arginate, GHK-Cu — mechanism, dosing, half-life, side effects, and research status.
| Attribute | Pentadeca Arginate Pentadeca Arginate (PDA) — BPC-157 Arginine Variant Recovery | GHK-Cu Glycyl-L-Histidyl-L-Lysine Copper Complex Recovery |
|---|---|---|
| Basics | ||
| Molecular type | Pentadecapeptide Arginine Analogue | Copper-Binding Tripeptide |
| Amino acids | 15 | 3 |
| Molecular weight | 1,476.6 Da | 340.4 Da |
| Half-life | ~4–6 hrs (estimated) | Short (minutes to hours) |
| Route(s) | Subcutaneous, Intramuscular, Oral (research) | Subcutaneous, Topical (skin), IV (research) |
| Mechanism & Research | ||
| Primary mechanism | PDA shares BPC-157's primary mechanism of action: nitric oxide (NO) synthase upregulation, VEGFR2-mediated angiogenesis, and connective tissue repair signalling. The arginine modification may further amplify NO pathway a… | GHK-Cu forms a stable complex with copper(II), which is essential for its biological activity. The copper complex activates collagenase and other metalloproteinases that remodel damaged extracellular matrix while simulta… |
| Research status | Research Compound | Research Compound |
| Evidence summary | PDA is a newer research compound with a smaller published evidence base than BPC-157. Most researchers extrapolate from BPC-157's extensive preclinical data given the structural and mechanistic similarity. Direct compara… | GHK-Cu is one of the most thoroughly researched cosmetic and wound-healing peptides. Topical GHK-Cu is commercially used in skincare. Deeper systemic applications (anti-aging, neuroprotection, systemic collagen support) … |
| Protocol & Dosing | ||
| Typical dose | 200–500 mcg per injection | 1–2 mg/day (SC); topical as needed |
| Frequency | Once or twice daily | Daily |
| Duration | 4–12 weeks | 8–12 weeks |
| Timing | Near injury site when possible; any time | Any time of day |
| Safety | ||
| Common side effects |
|
|
| Contraindications |
|
|
| Anti-doping | Prohibited (WADA S0) | Not Prohibited |
| Deeper reading | ||
| Related peptides | BPC-157, TB-500, GHK-Cu | BPC-157, Epithalon, LL-37 |
| Full profile | Read full Pentadeca Arginate profile → | Read full GHK-Cu profile → |
Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.